Alexander M Lesokhin

54PUBLICATIONS
211CO-AUTHORS
Medical mycologyHaematological tumoursMedical bacteriologyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Oct 06, 2026
Chromatin-informed cell-free DNA approach for detection of clinically measurable disease in multiple myeloma.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jun 12, 2026
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Feb 17, 2026
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

Pageof 9

Frequent Collaborators

30 joint publications

Urvi Shah

24 joint publications

Kylee Maclachlan

24 joint publications

Neha S Korde

24 joint publications

Heather Landau